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INTRODUCTION 
Antibiotics have long been considered the “magic bullet” 
that would end infectious disease. Although they have 
improved the health of countless numbers of humans and 
animals, many antibiotics have also been losing their 
effectiveness since the beginning of the antibiotic era. 
Bacteria have adapted defenses against these antibiotics 
and continue to develop new resistances, even as we 
develop new antibiotics. In recent years, much attention 
has been given to the increase in antibiotic resistance. As 
more microbial species and strains become resistant, 
many diseases have become difficult to treat, a 
phenomenon frequently ascribed to both indiscriminate 
and inappropriate use of antibiotics in humans1. There is 
no doubt that the use of antibiotics provides selective 
pressure that results in antibiotic resistant bacteria and 
resistance genes. 
In the past 60 years, antibiotics have been critical in the 
fight against infectious disease caused by bacteria and 
other microbes. Antimicrobial chemotherapy has been a 
leading cause for the dramatic rise of average life 
expectancy in the Twentieth Century. However, disease-
causing microbes that have become resistant to antibiotic 
drug therapy are an increasing public health problem. 
Wound infections, gonorrhea, tuberculosis, pneumonia, 
septicemia and childhood ear infections are just a few of 
the diseases that have become hard to treat with 
antibiotics. The increasing prevalence of antimicrobial-
resistant organisms is a major public health problem. 
Nowadays, about 70 percent of the bacteria that cause 
infections in hospitals are resistant to at least one of the 
drugs most commonly used for treatment2. 
Bloodstream infections cause substantial morbidity and 
mortality. Increasing rates of antimicrobial resistance, 
changing patterns of antimicrobial usage, and the wide 
application of new medical technologies (e.g., indwelling 
catheters and other devices) may change the 
epidemiology and outcome of bloodstream infection. It is 
therefore important to continually review and update the 
epidemiology3. 
METHODOLOGY 
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The study was conducted from data collected from 
patients admitted in various hospitals attached to Dr. S.N 
Medical College Jodhpur. A total of 512 cases with 
blood culture positive by Bact Alert method were 
included in this study. The name, age, sex, complete 
clinical history, organism isolated and their antibiotic 
sensitivity of all the patients were recorded in a pre-
designed performa. BacT/ALERT*FA culture bottles 
manufactured by BIOMERIEUX was used with the 
BacT/ALERT microbial detection system for enhanced 
recovery and detection of aerobic and facultative 
anaerobic microorganisms. The BacT/ALERT microbial 
detection system utilizes a colorimetric sensor and 
reflected light to monitor the presence and production of 
carbon dioxide that is dissolved in the culture medium4. 
Sub-Culture was done on blood agar, chocolate agar and 
thioglycollate broth and kept in 10% carbon dioxide 
atmosphere at 37 C for 48 hours and checked for growth 
after overnight incubation. If any colony was found on 
blood agar and chocolate agar then Gram’s staining was 
performed and subsequent bacterial identification was 
done by using biochemical tests. Antimicrobial 
sensitivity testing was performed by the Kirby Bauer 
Disc Diffusion Method. 
RESULTS 
List of organisms isolated from samples are illustrated in 
table 1. 
The sensitivity pattern of these isolated organisms is 
illustrated in table 2. 
Isolation of organisms based on underlying illness is 
illustrated in table 3. 
Table 1: Organisms Isolated In the Study 
 
As shown in table 1, the most common organisms 
isolated are Staph aureus accounting for 29.5% of the 
isolates and is followed by Klebsiella (13.87%), 
Enterococci (7.81%) and Citrobacter (7.42%) 
respectively.
Table 2: Sensitivity Pattern of Organisms 
ANTIBIOTIC 
Staph aureus Klebsiella Enterococci Citrobacter Enterobacter 
Total 
151 
% 
Total 
71 
% 
Total 
40 
% 
Total 
38 
% 
Total  
34 
% 
Ciprofloxacin (CP) 61 40.39 23 32.39 14 35 13 34.21 9 26.47 
Amoxycillin+sulbactum(Ams) 45 29.80 21 29.58 21 52.5 15 39.47 11 32.3 
Amikacin (AK) 25 16.56 22 30.99 12 30 23 60.53 15 44.12 
Ofloxacin (OF) 44 29.14 17 23.94 - - 15 39.47 8 23.53 
Tazobactum+Pipercillin(TzP) 34 22.5 34 47.89 16 40 13 34.21 5 14.71 
Tigecycline(Tgc) 36 23.84 22 44.89 7 33.33 20 52.63 13 38.02 
Gatifloxacin(GF) 52 34.44 - - - - 7 18.42 5 14.71 
Meropenem(MEM) 51 33.77 29 40.84 10 25 21 55.26 12 35.29 
Cefepime/Tazobac(CPT) 31 20.53 26 36.62 5 12.50 21 55.26 7 20.59 
Moxifloxacin (MXF) 32 21.19 18 25.35 7 17.05 6 15.78 5 14.71 
Pefloxacin (PF) 30 19.87 20 28.16 - - 13 34.21 1 2.94 
Vancomycin (VA) 44 35.76 - - 12 30 9 23.68 4 11.76 
 
The observations tabulated in table 2 shows that Staph 
aureus was most sensitive to Ciprofloxacin, Klebsiella to 
Tazobactum+Pipercillin (TzP), Enterococci to 
Amoxycillin+sulbactum (Ams), Citrobacter and 
Enterobacter were both most sensitive to Amikacin. 
The observations recorded in table 3 exhibits that Staph. 
aureus and Klebsiella are the most common isolates in 
patients with Diabetes Mellitus while Klebsiella, E.coli 
and Citrobacter are the major isolates in patients with 
UTI. 
In patients with Pneumonia; Staph. aureus, Klebsiella 
and Streptococci are major pathogens. While for 
Puerperal sepsis; Staph. aureus, Pseudomonas and 
Enterococci are major isolated pathogens.
 
Organism 
Total Number 
of Patients 
 
(%) 
Staph. Aureus 151 29.49 
Klebsiella 71 13.87 
Enterococci 40 7.81 
Citrobacter 38 7.42 
Enterobacter 34 6.64 
Staph. Albus 31 6.05 
Pseudomonas 27 5.27 
Candida albicans 18 3.52 
E. coli 18 3.52 
Salmonella 13 2.54 
Rest all others 71 13.87 
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TABLE 3: Isolation of Organism based on underlying illness 
Organism Diabetes Mellitus UTI Pneumonia Puerperal sepsis 
Staph. aureus 29 1 30 5 
Klebsiella 17 20 10 0 
Pseudomonas 8 8 1 3 
Candida albicans 7 3 0 0 
Enterococci 7 9 1 2 
Enterobacter 6 0 0 1 
Citrobacter 4 12 1 1 
Providencia 3 2 1 0 
Streptococci 3 0 6 1 
E. coli 1 13 0 1 
Rest all others 6 4 0 2 
 
DISCUSSION 
The inappropriate use of antibiotics has resulted in selection 
of large number of resistant strains
5
. To overcome this 
problem, the understanding of microbial flora and their 
sensitivity profile is essential. 
The four most common organisms isolated in this study 
were Staphylococcus aureus (29.49%), Klebsiella (13.8%), 
Enterococci (7.8%) & Citrobacter (7.4%). 
The observations made in this study shows that Staph 
aureus was most sensitive to Ciprofloxacin, Klebsiella to 
Tazobactum+Pipercillin (TzP), Enterococci to 
Amoxycillin+sulbactum (Ams), Citrobacter and Enterobeter 
were both most sensitive to Amikacin. 
The antibiotic sensitivity patterns of individual organisms 
isolated from the study sample were analysed. In the present 
study, it was observed that the Staph. aureus was most 
susceptible to fluroquinolones followed by Amoxycillin + 
Sulbactum (29.8%) & Vancomycin (35.76%). Klebsiella 
was most susceptible to Tazobactum + Pipercillin (47%) 
followed by Cefepime + Tazobactum (36.6%), Meropenem 
& Ciprofloxacin both 32.3%. Enterococci was most 
susceptible to Amoxycillin+sulbactum (52.5%) followed by 
Tazobactum+Pipercillin (40%), Amikacin (30%), 
Vancomycin (30%), Meropenem (25%) and Tigecycline 
(25%). Citrobacter was most susceptible to Amikacin 
(60.53%) followed by Meropenem and Cefepime + 
Tazobactum both in 55.26%, Tigecycline (52.63%) and 
tetracycline in 42.11% cases. E.coli was susceptible to 
Meropenem (38.8%) followed by Ciprofloxacin (33.33%), 
Amikacin (22.22%). 
The source of infection and underlying illness in these 
patients was analysed, it revealed that the diabetes was the 
major underlying illness in 15.1% cases followed by urinary 
tract infection (12.1%) & Pneumonia (9.54%). 
The result of EPIC study performed in Europe in 1992, also 
showed that the Pneumonia was the most common infection 
(46.9%) followed by UTI (17.6%)
6
. NNIS study from USA 
identified UTI (31%) as the most common infection in 
patients with sepsis followed by Pneumonia (27%)
2
. 
Staphylococcus aureus & Klebsiella accounting for 46%, 
were the most common organism causing infection in 
patients with Diabetes Mellitus. Staph. aureus, 
Pseudomonas & Enterococci were the most common 
organisms causing Puerperal sepsis. 
CONCLUSION 
The present study shows that there are constantly changing 
patterns of microorganisms causing infections along with 
their antibiotic sensitivity. It has been noted that the 
pathogens causing infections are also dependent on the 
underlying illness such as Diabetes Mellitus, UTI, and 
Pneumonia. This is also an important aspect to be 
considered by the clinician while prescribing antibiotics to 
such population.  
Thus, this study clearly emphasizes the importance of early 
identification of the organism and their sensitivity pattern 
using latest techniques, which will surely decreases the 
mortality and morbidity in patients. Further, judicious use of 
antibiotics will not only reduce the development of 
antibiotic resistance but also would lessen the economic 
burden on the patients. 
The present study also proposes the importance of such 
studies to be conducted at regular intervals to determine 
latest trends in microbial infections and their sensitivity 
patterns.
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